Font Size




Menu Style

Return to Menu


Click here for the Options IX Programme

Click here for the Options IX Programme + Abstracts (9307KB)

Opening Plenary Session: Keynote Address 
Nancy Cox, PhD
Past Director of the Influenza Division at the Centers for Disease Control and Prevention (CDC) and Director of CDC's World Health Organization (WHO) Collaborating Center for Surveillance, Epidemiology and Control of influenza
IMG 0040                                                         

IMG 0067

IMG 0041

IMG 0056

IMG 0045

IMG 0048

IMG 0049

IMG 0050

IMG 0059

IMG 0089
IMG 0076
IMG 0096
IMG 0101
Public Health Plenary Session:
Addressing the Public Health Threat of Influenza: Recognition, Prevention and Treatment
Nahoko Shindo, MD, PhD
World Health Organisation, Geneva, Switzerland

Werner Bischoff, MD, PhD
Wake Forest University School of Medicine, Salem, NC, USA.

Yuelong Shu, PhD
Chinese National Influenza Center, National Institute for Viral Disease, Control and Prevention, Beijing, China.

Virology & Pathogenesis Plenary Session:
Molecular Studies for Vaccines and Antivirals

Structure, Mechanism and Drug Targeting of Influenza Polymerase (not available)
Stephen Cusack, PhD, FRS
European Molecular Biology Laboratory, Grenoble Outstation, Grenoble, France.

Toward a Universal Influenza Virus (revised)
Peter Palese
Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Influenza Countermeasures (not available)
Yoshihiro Kawaoka, DVM, PhD
University of Wisconsin-Madison/University of Tokyo, Madison, WI, USA
Clinical Science Plenary Session:
Newer Therapies for Influenza: Hurdles and Progress
Clinical Development Challenges: Trial Designs and Endpoints
Menno de Jong, MD, PhD
University of Amsterdam, Amsterdam, The Netherlands.
Novel Antiviral Agents in Advanced Development (not available)
Frederick Hayden, MD
University of Virginia School of Medicine, Charlottesville, VA, USA.

Combination Antivirals and Antibody-Based Therapies
John Beigel, MDLeidos/NIAID, Bethsheda, MD, USA.

Closing Plenary Session:
The Future Threats from Influenza
Influenza at the Animal-Human Interface
David Swayne, DVM, PhD
National Poultry Research Center - USDA, Athens, GA, USA.
Forecasting the Future of Flu
Trevor Bedford, PhD
Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

 Improving on Influenza Vaccines: Managing the Challenges of Vaccine Mismatch
Dan Jernigan, MD, MPH
US Centers for Disease Control and Prevention, Atlanta, GA, USA.

Recap Video